コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 eview and attributable to surgical issues of donor nephrectomy.
2 ipient morbidity following laparoscopic live donor nephrectomy.
3 equently encountered with laparoscopic right donor nephrectomy.
4 ensation to those persons willing to undergo donor nephrectomy.
5 nephrectomy, radical nephroureterectomy and donor nephrectomy.
6 the use of ketorolac for patients undergoing donor nephrectomy.
7 protamine administration during laparoscopic donor nephrectomy.
8 s who are candidates for laparoscopic living-donor nephrectomy.
9 ractive alternative to standard laparoscopic donor nephrectomy.
10 the safety of using ketorolac at the time of donor nephrectomy.
11 renal arteries and would have undergone left donor nephrectomy.
12 centers performing right-sided laparoscopic donor nephrectomy.
13 tailored informed consent procedure for live donor nephrectomy.
14 phrectomy is feasible and equivalent to open donor nephrectomy.
15 reduced LOS and decreased narcotic use after donor nephrectomy.
16 ansion is important during laparoscopic live donor nephrectomy.
17 re of choice as compared to traditional open donor nephrectomy.
18 bjective improvements to laparoscopic living donor nephrectomy.
19 in 10 in situ native adult kidneys prior to donor nephrectomy.
20 to historic control subjects undergoing open donor nephrectomy.
21 t areas and kidney function before and after donor nephrectomy.
22 r ureteral complications solely after living donor nephrectomy.
23 ogression through donor assessment to actual donor nephrectomy.
24 to the laparoscopic approach for left-sided donor nephrectomy.
25 with traditional multiple-port laparoscopic donor nephrectomy.
26 donor evaluation, well before scheduling the donor nephrectomy.
27 tion (LKT) after retroperitoneoscopic living-donor nephrectomy.
28 as the main reason for still performing open donor nephrectomy.
29 opment of novel surgical techniques for live-donor nephrectomy.
30 y morphine requirements in laparoscopic live-donor nephrectomy.
31 to track the unknown consequences of a live-donor nephrectomy.
32 vices to secure the vein during laparoscopic donor nephrectomy.
33 albumin did not change in either group after donor nephrectomy.
34 re important features of a successful living-donor nephrectomy.
35 iteria that have traditionally governed open donor nephrectomy.
36 tients were assessed in a series of 150 live-donor nephrectomies.
37 tiinstitutional review of laparoscopic right donor nephrectomies.
38 omes compared with all previous laparoscopic donor nephrectomies.
39 ing cohort of 100 multiple-port laparoscopic donor nephrectomies.
40 tal center experience with 1300 laparoscopic donor nephrectomies.
41 e implemented RetroNeph at once for all live donor nephrectomies.
42 1/1/1990 and 12/31/2014, we did 2002 living donor nephrectomies.
46 with the current advantages of laparoscopic donor nephrectomy and may continue to decrease disincent
48 ladder cancer), kidney surgery (nephrectomy, donor nephrectomy and pyeloplasty), and adrenal surgery.
49 high-risk (renal transplant and laparoscopic donor nephrectomy) and low-risk (arteriovenous fistula f
50 , surgery date, coordination of simultaneous donor nephrectomies, and other issues are coordinated as
51 ween the cohort that did and did not undergo donor nephrectomy, and performed simple linear logistic
52 splenectomy for splenomegaly, living-related donor nephrectomy, and procedures considered too complex
55 used techniques for minimally invasive live donor nephrectomy are safe and associated with low compl
58 (LDN) has become the gold standard for live-donor nephrectomy, as it results in a short convalescenc
59 A 25-year-old man underwent laparoscopic donor nephrectomy at a large medical center familiar wit
61 tion after hand-assisted laparoscopic living donor nephrectomy at our institution from January 2008 t
64 nsecutive patients who underwent open living donor nephrectomy between January 1998 and July 2000 at
65 nd function rates are equal to those of open donor nephrectomy, but longer follow-up is necessary to
71 from a Medicare perspective for laparoscopic donor nephrectomy compared with living and cadaveric tra
73 of minimally invasive surgical approaches to donor nephrectomy (DN) has been driven by the potential
78 Between 2000 and December 2013, 106 live donor nephrectomies from anonymous living-donors were pe
79 splenectomy for splenomegaly, living-related donor nephrectomy, gastric banding for morbid obesity, p
80 study was to determine whether laparoscopic donor nephrectomy had any deleterious effect on the reci
81 e infection after hand-assisted laparoscopic donor nephrectomy (HALDN) confers significant morbidity
91 troduction of minimal invasive, laparoscopic donor nephrectomy has increased live kidney donation, pa
92 idity, and short-term graft function to open donor nephrectomy has not been performed previously.
99 ecall of the Hem-o-lok clip for laparoscopic donor nephrectomies in 2006, two live kidney donors in t
104 y donation in general and minimally invasive donor nephrectomy in particular are more commonly applie
105 nt programs must weigh risks of performing a donor nephrectomy in those with 2 APOL1 renal risk varia
106 few, recent studies suggest that GFR loss at donor nephrectomy increases the risk of eventual end-sta
113 Initial reports suggest that laparoscopic donor nephrectomy is feasible and equivalent to open don
116 Based on these results, we conclude that donor nephrectomy is not detrimental to the prenatal cou
119 lar injury, many studies have suggested that donor nephrectomy itself does not cause long-term loss o
122 vely review the results of laparoscopic live donor nephrectomy (LapNx) and to compare them with those
123 on to six kidneys removed after laparoscopic donor nephrectomy (LDN) and several hours of CO2 pneumop
131 ncision open donor nephrectomy, laparoscopic donor nephrectomy (LDN) is considered cost-effective.
133 There is controversy whether laparoscopic donor nephrectomy (LDN) is the procedure of choice for l
135 of life after randomization to laparoscopic donor nephrectomy (LDN) or short-incision open donor nep
138 atomic and functional outcomes of right live-donor nephrectomy (LDN) using either a hand-assisted app
140 aparoscopic kidney procurement (laparoscopic donor nephrectomy [LDN]) in adults, doubts have persiste
142 ents and three cases where laparoscopic live donor nephrectomy (LLDN) was utilized to obtain the kidn
151 rocedures compared were the traditional open donor nephrectomy [ODN], the standard laparoscopic [LAP]
153 examines the short-term (3 months) effect of donor nephrectomy on GFR and the occurrence of stage 3 c
154 were higher than open and left laparoscopic donor nephrectomy on postoperative day 1, but at all rem
157 ociated perioperative morbidity, we reviewed donor nephrectomies performed at our institution from Ja
158 rospectively analyzed all right laparoscopic donor nephrectomies performed at their center from Novem
159 m 52 consecutive living-related laparoscopic donor nephrectomies performed at University of Californi
161 describes the authors' large series of right donor nephrectomies performed laparoscopically without t
162 ases of robotic-assisted laparoscopic living donor nephrectomy performed using the da Vinci Surgical
163 erience demonstrates that laparoscopic right donor nephrectomy performed without hand-assist devices
166 eficial alternative to the conventional open donor nephrectomy procedure and cadaveric transplantatio
167 y 1998 to December 1998 and traditional open donor nephrectomy procedures from May 1996 to May 1998 s
168 roscopic as compared with open surgical live donor nephrectomy provides briefer, less intense, and mo
169 ymer ligating (NPL) clip during laparoscopic donor nephrectomy provides increased graft vessel length
170 hese results confirm that right laparoscopic donor nephrectomy provides similar patient benefits, inc
171 echnique for kidney living donation, robotic donor nephrectomy (RDN) settled as another appealing min
172 toperative pain for patients undergoing open donor nephrectomy reduced morbidity and was not associat
176 o developed a complication from laparoscopic donor nephrectomy that required open corrective surgery.
180 le means of arterial control in laparoscopic donor nephrectomy; thus, a practice with documented fata
181 oup of patients undergoing laparoscopic live donor nephrectomy to a group of patients undergoing open
182 ctomy to a group of patients undergoing open donor nephrectomy to assess the efficacy, morbidity, and
184 mong 480 renal transplantations after living donor nephrectomy, ureteral complications occurred in 18
185 was to compare laparoscopic versus open live donor nephrectomy using meta-analytical techniques.
191 stain closure of renal artery stumps in live donor nephrectomies were received, this study was design
192 Records from 381 consecutive laparoscopic donor nephrectomies were reviewed with evaluation of bot
194 ies of patients undergoing laparoscopic live donor nephrectomy were compared to historic control subj
197 We compared outcomes from 135 single-port donor nephrectomies with an immediately preceding cohort
198 h morbidity and mortality comparable to open donor nephrectomy, with substantial improvements in pati
199 35 patients completed successful single-port donor nephrectomy without major complication or open con